Cargando…
Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype–phenotype spectrum
A subset of patients with polyglucosan body myopathy was found to have underlying mutations in the RBCK1 gene. Affected patients may display diverse symptoms ranging from skeletal muscular weakness, cardiomyopathy to chronic autoinflammation and immunodeficiency. It was suggested that the exact loca...
Autores principales: | Krenn, Martin, Salzer, Elisabeth, Simonitsch-Klupp, Ingrid, Rath, Jakob, Wagner, Matias, Haack, Tobias B., Strom, Tim M., Schänzer, Anne, Kilimann, Manfred W., Schmidt, Ralf L. J., Schmetterer, Klaus G., Zimprich, Alexander, Boztug, Kaan, Hahn, Andreas, Zimprich, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808061/ https://www.ncbi.nlm.nih.gov/pubmed/29260357 http://dx.doi.org/10.1007/s00415-017-8710-x |
Ejemplares similares
-
A novel variant of RBCK1 gene causes mild polyglucosan
myopathy
por: AlAnzi, Talal, et al.
Publicado: (2022) -
GYG1: A distal myopathy with polyglucosan bodies
por: Nicolau, Stefan, et al.
Publicado: (2020) -
GYG1 gene mutations in a family with polyglucosan body myopathy
por: Fanin, Marina, et al.
Publicado: (2015) -
The TGF‐b/SOX4 axis and ROS‐driven autophagy co‐mediate CD39 expression in regulatory T‐cells
por: Gerner, Marlene C., et al.
Publicado: (2020) -
Characterization of cognitive impairment in adult polyglucosan body disease
por: Zebhauser, Paul Theo, et al.
Publicado: (2022)